Risk Factors of Diabetes in North Indians with Metabolic Syndrome
Overview
Affiliations
Aim: Metabolic syndrome progresses to diabetes and determinants of this progression like hyperinsulinemia, hypertriglyceridemia and genetic factors have been speculative. The present study was aimed at quantifying the insulin resistance and influence of family history of diabetes in subjects with metabolic syndrome developing prediabetes and diabetes.
Methods: Consecutive subjects attending the endocrine clinic were evaluated for metabolic syndrome as per definition of International Diabetes Federation, 2005. The family history of diabetes in their first degree relatives was ascertained and Homeostasis model assessment of Insulin resistance (HOMA-IR), Homeostasis model assessment for beta cell function (HOMA-B) and Quantitative insulin sensitivity check index (QUICKI) were calculated in 163 subjects enrolled.
Results: HOMA-IR was higher (p<0.05) but HOMA-B and QUICKI were lower (p<0.0001) in subjects with metabolic syndrome+prediabetes or diabetes compared to metabolic syndrome with normal glucose tolerance. HOMA-B was lower and prevalence of prediabetes and diabetes was higher in metabolic syndrome subjects with family history of diabetes than in those without such family history (p<0.05).
Conclusions: subjects with metabolic syndrome having prediabetes and diabetes had more severe insulin resistance than those with metabolic syndrome only. Beta cell dysfunction was remarkable and prevalence of prediabetes was high in metabolic syndrome subjects with family history of diabetes. Both the severity of the insulin resistance and family history of diabetes are therefore proposed to be determinants of diminished Beta cell function leading to diabetes in metabolic syndrome.
Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptoms.
Wang J, Zhang Y, Liu Z, Yang Y, Zhong Y, Ning X BMC Psychiatry. 2020; 20(1):410.
PMID: 32811450 PMC: 7437037. DOI: 10.1186/s12888-020-02809-4.
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020.
Chawla R, Madhu S, Makkar B, Ghosh S, Saboo B, Kalra S Indian J Endocrinol Metab. 2020; 24(1):1-122.
PMID: 32699774 PMC: 7328526. DOI: 10.4103/ijem.IJEM_225_20.
Wang J, Wang Y, Chen F, Ma G, Wang D Med Sci Monit. 2020; 26:e916459.
PMID: 31958336 PMC: 6990664. DOI: 10.12659/MSM.916459.
Carbohydrate status in patients with phenylketonuria.
Couce M, Sanchez-Pintos P, Vitoria I, De Castro M, Aldamiz-Echevarria L, Correcher P Orphanet J Rare Dis. 2018; 13(1):103.
PMID: 29945661 PMC: 6020344. DOI: 10.1186/s13023-018-0847-x.
Myers E, Trostler N, Varsha V, Voet H Top Clin Nutr. 2017; 32(1):69-86.
PMID: 28232773 PMC: 5302411. DOI: 10.1097/TIN.0000000000000089.